Oppenheimer & CO Inc Bausch Health Companies Inc. Transaction History

Oppenheimer & CO Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$6.1 - $10.41 $515,602 - $879,905	84,525 New	84,525 $589,000
Q4 2021 Feb 02, 2022	SELL	$23.0 - $29.01 $170,844 - $215,486	-7,428 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $12,494 - $14,999	-499 Reduced 6.29%	7,428 $207,000
Q2 2021 Aug 03, 2021	BUY	$27.43 - $32.7 $30,173 - $35,970	1,100 Added 16.11%	7,927 $232,000
Q1 2021 May 10, 2021	SELL	$21.37 - $34.38 $64,110 - $103,140	-3,000 Reduced 30.53%	6,827 $217,000
Q4 2020 Feb 11, 2021	SELL	$15.31 - $21.12 $3,062 - $4,224	-200 Reduced 1.99%	9,827 $205,000
Q3 2020 Nov 13, 2020	SELL	$14.88 - $20.13 $139,872 - $189,222	-9,400 Reduced 48.39%	10,027 $156,000
Q2 2020 Aug 11, 2020	BUY	$13.31 - $20.51 $918 - $1,415	69 Added 0.36%	19,427 $355,000
Q1 2020 May 08, 2020	BUY	$12.98 - $30.25 $95,571 - $222,730	7,363 Added 61.38%	19,358 $300,000
Q4 2019 Feb 07, 2020	BUY	$18.89 - $31.89 $226,585 - $382,520	11,995 New	11,995 $359,000
Q4 2018 Jan 29, 2019	SELL	$17.64 - $28.32 $259,907 - $417,266	-14,734 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$20.64 - $25.67 $304,109 - $378,221	14,734 New	14,734 $378,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.